Comprehensive evaluation of the quality characteristics of new drugs is helpful for their marketing. However, the quality evaluation indictors of new drugs are too simple, and too many evaluation indictors may cause respondents to reject and perfunctory, leading to the evaluation results are not reliable enough. In this study, a fuzzy clustering method was proposed to optimize the quality characteristics of new drugs and simplify the evaluation process.

Peng Ruan. Study on the New Drug Quality Characteristic Evaluation Indictor by Fuzzy Clustering Method. Academic Journal of Humanities & Social Sciences (2020) Vol. 3, Issue 1: 15-25. https://doi.org/10.25236/AJHSS.2020.030103.

[1] Deng yong. Suggestions on improving the drug registration administration measures (draft for soliciting opinions) [N]. Democracy and legal times, 2019-10-31 (006).
[2] Jue xiao. Chinese new anticancer drug was approved for the first time in the us. People's Daily overseas edition. November 29, 2019
[3] Tong xiao, Chen yuwen. Analysis on the examination and approval of registration and application of five types of new traditional Chinese medicine drugs in China from 2009 to 2015 [J]. Chinese journal of pharmaceutical industry, 2008, 49 (09): 1327-1330.
[4] Lai shuqing, Wang qiwei, Liu jianhui. Analysis of new drug approval and registration application in China in 2017 [J]. Chinese journal of pharmaceutical industry, 2008, 49 (03): 392-396.
[5] Indrajit Saha, Jnanendra Prasad Sarkar, Ujjwal Maulik. Integrated Rough Fuzzy Clustering for Categorical data AnalysisFuzzy Sets and Systems, 2018, 23 (2): 7-8
[6] Sin-Jin Lin. Hybrid Kernelized Fuzzy Clustering and Multiple Attributes Decision Analysis for Corporate Risk Management. International Journal of Fuzzy Systems, 2017, 19 (3): 659-670